# The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy

> **NCT00113477** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Statin Therapy

## Interventions

- **DRUG:** Q10
- **DRUG:** Selen

## Key facts

- **NCT ID:** NCT00113477
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113477, "The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00113477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*